A Novel Heterozygous Germline Deletion in MSH2 Gene in a Five Generation Chinese Family with Lynch Syndrome
Overview
Authors
Affiliations
Lynch syndrome (LS) is one of the most common familial forms of colorectal cancer predisposing syndrome with an autosomal dominant mode of inheritance. LS is caused by the germline mutations in DNA mismatch repair (MMR) genes including and . Clinically, LS is characterized by high incidence of early-onset colorectal cancer as well as endometrial, small intestinal and urinary tract cancers, usually occur in the third to fourth decade of the life. Here we describe a five generation Chinese family with LS clinically diagnosed according to the Amsterdam II criteria. Immuno-histochemical staining of MSH2 and MSH6 shows only foci nuclear positive on the surface of the tumor with strong expression of MLH1 and PMS2 with diffuse immunoreactivity. In order to dig into the molecular basis of this LS pedigree, we collected the proband's blood sample, extracted the genomic DNA and applied the genetic screening. As a result, we identified a novel heterozygous deletion in gene by targeted next generation sequencing, which is also proved to be co-segregated among other affected family members by following validation. To our knowledge, this novel heterozygous deletion (c.1676_1679 delTAAA) in gene causes frameshift mutation (p.Asn560Lysfs*29) and leads to the formation of a truncated MSH2 protein which is confirmed to be a deleterious mutation according to the variant interpretation guidelines of American College of Medical Genetics and Genomics (ACMG). Identification of novel DNA mismatch repair (MMR) gene mutations can definitely benefit to the clinical diagnosis and management.
A Novel Splice-Site Mutation in Is Associated With the Development of Lynch Syndrome.
Li J, Li Y, Ni H, Yang Z, Chen J, Li Y Front Oncol. 2020; 10:983.
PMID: 32637358 PMC: 7318799. DOI: 10.3389/fonc.2020.00983.
Shao W, Wang C, Wang L, Xiao F, Xiao D, Yang H Cancer Manag Res. 2020; 12:1469-1482.
PMID: 32161499 PMC: 7051253. DOI: 10.2147/CMAR.S222572.
Advances in Identification of Susceptibility Gene Defects of Hereditary Colorectal Cancer.
Liu Q, Tan Y J Cancer. 2019; 10(3):643-653.
PMID: 30719162 PMC: 6360424. DOI: 10.7150/jca.28542.
Zhang Y, Chen H, Peng Z, Banerjee S, Li W, Zhao Z Biomed Res Int. 2018; 2018:1460835.
PMID: 30539002 PMC: 6261076. DOI: 10.1155/2018/1460835.